SECOND SIGHT MEDICAL PRODUCT (EYES)

US81362J3086 - Common Stock

4.14  -0.22 (-5.05%)

After market: 4.0921 -0.05 (-1.16%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2019 2020 2021 2022 2023 2024
Revenue
YoY % growth
3.379M
-51.00%		2.814M
EBITDA
YoY % growth
-30.2M
11.67%		-12.503M
58.60%		-8.863M
29.11%		N/AN/AN/A
EBIT
YoY % growth
-30.597M
11.63%		-12.667M
58.60%		-8.933M
29.48%		N/AN/AN/A
Operating Margin
-905.50%N/AN/AN/AN/AN/A
EPS
YoY % growth
-6.54-0.85
87.00%		N/A-1.21

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 22
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		N/A
EBIT
Q2Q % growth		N/A

Recent Earnings VS Estimates Surprises ()
PeriodReportedEstimateDifferenceSurprise
Q4 2020
Q2Q % growth		 -0.06
96.00%		-0.440.3886.32%
Q3 2020
Q2Q % growth		 -0.07
95.14%		-0.430.3683.66%
Q2 2020
Q2Q % growth		 -0.45
73.21%		-1.250.8064.13%
Q1 2020
Q2Q % growth		 -1.71
10.94%		-1.25-0.46-36.30%
Recent Revenue VS Estimates Surprises

Reported revenue can not be compared with estimates as they are in different currencies. Reported data is in USD, while estimates are .

PeriodReportedEstimateDifferenceSurprise
Q4 2021
Q2Q % growth		 243.599K-243.599K-100.00%
Q4 2020
Q2Q % growth
-100.00%		245.629K-245.629K-100.00%
Q3 2020
Q2Q % growth
-100.00%		244.614K-244.614K-100.00%
Q2 2020
Q2Q % growth
-100.00%		244.8K-244.8K-100.00%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A N/A N/A
RevenueN/A N/A N/A N/A